Alzheimer's disease is the most common form of dementia in the elderly. Currently, there is no established standard treatment for this disease; therefore, the treatment of Alzheimer's disease will be a major challenge for physicians in the next decade in order to ameliorate quality of life of patients and reduce the costs for the communities.,
Journal of Alzheimer's Disease
Department of Internal Medicine

Mattace Raso, F.U.S. (2014). Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer's disease?. Journal of Alzheimer's Disease (Vol. 41, pp. 641–642). doi:10.3233/JAD-140016